The role of EGFR inhibitors in nonsmall cell lung cancer.
作者： Fortunato Ciardiello , Ferdinando De Vita , Michele Orditura , Giampaolo Tortora
DOI: 10.1097/00001622-200403000-00008
关键词:
摘要: … review focuses on the available clinical data on epidermal growth factor receptor-targeting drugs in the treatment of nonsmall cell lung … based on EGFR expression received either 250 …
lww.com
sci-hub.se 参考文章(41)
Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)
Mark G. Kris, Howard I. Scher, Vincent A. Miller, Maureen F. Zakowski, Francis M. Sirotnak, Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase Clinical Cancer Research. ,vol. 6, pp. 4885- 4892 ,(2000)
J. Baselga, D. Pfister, M.R. Cooper, R. Cohen, B. Burtness, M. Bos, G. D’Andrea, A. Seidman, L. Norton, K. Gunnett, J. Falcey, V. Anderson, H. Waksal, J. Mendelsohn, Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin Journal of Clinical Oncology. ,vol. 18, pp. 904- 914 ,(2000) , 10.1200/JCO.2000.18.4.904
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Nicola Normanno, Monica R. Maiello, Antonella De Luca, Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): Simple drugs with a complex mechanism of action? Journal of Cellular Physiology. ,vol. 194, pp. 13- 19 ,(2003) , 10.1002/JCP.10194
Susan F. Slovin, Govindaswami Ragupathi, Cristina Musselli, Krystyna Olkiewicz, David Verbel, Scott D. Kuduk, Jacob B. Schwarz, Dalibor Sames, Samuel Danishefsky, Philip O. Livingston, Howard I. Scher, Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine. Journal of Clinical Oncology. ,vol. 21, pp. 4292- 4298 ,(2003) , 10.1200/JCO.2003.04.112
Federico Cappuzzo, Andrea Ardizzoni, Hector Soto-Parra, Cesare Gridelli, Paolo Maione, Marcello Tiseo, Cesare Calandri, Stefania Bartolini, Armando Santoro, Lucio Crinò, Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC) Lung Cancer. ,vol. 41, pp. 227- 231 ,(2003) , 10.1016/S0169-5002(03)00189-2
Janet E Dancey, Boris Freidlin, Targeting epidermal growth factor receptor--are we missing the mark? The Lancet. ,vol. 362, pp. 62- 64 ,(2003) , 10.1016/S0140-6736(03)13810-X
J.R Woodburn, The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacology & Therapeutics. ,vol. 82, pp. 241- 250 ,(1999) , 10.1016/S0163-7258(98)00045-X
John Mendelsohn, Jose Baselga, Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer Journal of Clinical Oncology. ,vol. 21, pp. 2787- 2799 ,(2003) , 10.1200/JCO.2003.01.504